Sopharma AD reports sale of treasury shares on Bulgarian Stock Exchange

Ognyan Ivanov Donev Chairman of the Board of Directors and Executive Director Sopharma AD
Ognyan Ivanov Donev Chairman of the Board of Directors and Executive Director - Sopharma AD
0Comments

Sopharma AD has announced the sale of 28,720 treasury shares on September 26, 2025. The transaction took place on the Bulgarian Stock Exchange, with a total value of BGN 77,133.80 and an average price per share of BGN 2.69. These shares represent 0.01% of the company’s share capital.

Following this sale, Sopharma AD holds a total of 19,902,101 treasury shares, which account for 3.69% of its share capital.

The company made this notification in accordance with Article 17 of Regulation (EU) No 596/2014 of the European Parliament and Council.



Leave a Reply

Your email address will not be published. Required fields are marked *

Related

Oliver Bäte Chairman of the Board of Management of Allianz SE (CEO) Allianz SE

Allianz reports financial performance and sustainability achievements for 2024

The Allianz Group operates as a major insurer and asset manager, serving private and corporate clients in almost 70 countries.

Oliver Bäte Chairman of the Board of Management of Allianz SE (CEO) Allianz SE

Allianz Group highlights global operations and sustainability leadership

Allianz Group, a major global insurer and asset manager, operates in nearly 70 countries.

Aditya Mittal Chief executive officer ArcelorMittal

ArcelorMittal posts Q3 2025 earnings; highlights EU policy momentum

ArcelorMittal has released its financial results for the third quarter of 2025, reporting earnings before interest, taxes, depreciation and amortization (EBITDA) of $1.5 billion and a net income of $0.4 billion for the period ending September 30,…

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from EU Business Daily.